First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
Saved in:
| Title: | First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial. |
|---|---|
| Authors: | Waalewijn H; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa., Szubert AJ; Medical Research Council Clinical Trials Unit, University College London, United Kingdom., Wasmann RE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa., Chabala C; Department of Paediatrics and Child Health, School of Medicine, University of Zambia.; Children's Hospital, University Teaching Hospital, Lusaka, Zambia., Bwakura-Dangarembizi M; University of Zimbabwe Clinical Research Centre, Harare., Makumbi S; Joint Clinical Research Centre, Mbarara Regional Centre of Excellence, Mbarara, Uganda., Nangiya J; Joint Clinical Research Centre, Research Department, Kampala, Uganda., Mumbiro V; University of Zimbabwe Clinical Research Centre, Harare., Mulenga V; Children's Hospital, University Teaching Hospital, Lusaka, Zambia., Musiime V; Joint Clinical Research Centre, Research Department, Kampala, Uganda.; Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda., Monkiewicz LN; Medical Research Council Clinical Trials Unit, University College London, United Kingdom., Griffiths AL; Medical Research Council Clinical Trials Unit, University College London, United Kingdom., Bamford A; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Doerholt K; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.; Paediatric Infectious Diseases Unit, St George's University Hospital, London, United Kingdom., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa., Burger DM; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Gibb DM; Medical Research Council Clinical Trials Unit, University College London, United Kingdom., McIlleron HM; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa., Colbers A; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. |
| Corporate Authors: | Children with HIV in Africa – Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens (CHAPAS-4) Trial Team |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Sep 18; Vol. 77 (6), pp. 875-882. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37315296 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Waalewijn+H%22">Waalewijn H</searchLink>; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Szubert+AJ%22">Szubert AJ</searchLink>; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wasmann+RE%22">Wasmann RE</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Wiesner+L%22">Wiesner L</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Chabala+C%22">Chabala C</searchLink>; Department of Paediatrics and Child Health, School of Medicine, University of Zambia.; Children's Hospital, University Teaching Hospital, Lusaka, Zambia.<br /><searchLink fieldCode="AU" term="%22Bwakura-Dangarembizi+M%22">Bwakura-Dangarembizi M</searchLink>; University of Zimbabwe Clinical Research Centre, Harare.<br /><searchLink fieldCode="AU" term="%22Makumbi+S%22">Makumbi S</searchLink>; Joint Clinical Research Centre, Mbarara Regional Centre of Excellence, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Nangiya+J%22">Nangiya J</searchLink>; Joint Clinical Research Centre, Research Department, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Mumbiro+V%22">Mumbiro V</searchLink>; University of Zimbabwe Clinical Research Centre, Harare.<br /><searchLink fieldCode="AU" term="%22Mulenga+V%22">Mulenga V</searchLink>; Children's Hospital, University Teaching Hospital, Lusaka, Zambia.<br /><searchLink fieldCode="AU" term="%22Musiime+V%22">Musiime V</searchLink>; Joint Clinical Research Centre, Research Department, Kampala, Uganda.; Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Monkiewicz+LN%22">Monkiewicz LN</searchLink>; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Griffiths+AL%22">Griffiths AL</searchLink>; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bamford+A%22">Bamford A</searchLink>; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Doerholt+K%22">Doerholt K</searchLink>; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.; Paediatric Infectious Diseases Unit, St George's University Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Denti+P%22">Denti P</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Burger+DM%22">Burger DM</searchLink>; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gibb+DM%22">Gibb DM</searchLink>; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McIlleron+HM%22">McIlleron HM</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Colbers+A%22">Colbers A</searchLink>; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Children+with+HIV+in+Africa+–+Pharmacokinetics+and+Acceptability+of+Simple+second-line+antiretroviral+regimens+%28CHAPAS-4%29+Trial+Team%22">Children with HIV in Africa – Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens (CHAPAS-4) Trial Team</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2023 Sep 18; Vol. 77 (6), pp. 875-882. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37315296 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciad267 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 875 Titles: – TitleFull: First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Waalewijn H – PersonEntity: Name: NameFull: Szubert AJ – PersonEntity: Name: NameFull: Wasmann RE – PersonEntity: Name: NameFull: Wiesner L – PersonEntity: Name: NameFull: Chabala C – PersonEntity: Name: NameFull: Bwakura-Dangarembizi M – PersonEntity: Name: NameFull: Makumbi S – PersonEntity: Name: NameFull: Nangiya J – PersonEntity: Name: NameFull: Mumbiro V – PersonEntity: Name: NameFull: Mulenga V – PersonEntity: Name: NameFull: Musiime V – PersonEntity: Name: NameFull: Monkiewicz LN – PersonEntity: Name: NameFull: Griffiths AL – PersonEntity: Name: NameFull: Bamford A – PersonEntity: Name: NameFull: Doerholt K – PersonEntity: Name: NameFull: Denti P – PersonEntity: Name: NameFull: Burger DM – PersonEntity: Name: NameFull: Gibb DM – PersonEntity: Name: NameFull: McIlleron HM – PersonEntity: Name: NameFull: Colbers A IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 09 Text: 2023 Sep 18 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 77 – Type: issue Value: 6 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |
